Waratah Capital Advisors Ltd. Stryker Corp Transaction History

Waratah Capital Advisors Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$266.54 - $302.43 $2.21 Million - $2.51 Million	8,301 New	8,301 $2.27 Million
Q4 2022 Feb 10, 2023	SELL	$205.51 - $253.93 $1.11 Million - $1.38 Million	-5,418 Reduced 55.89%	4,276 $1.05 Million
Q3 2022 Nov 07, 2022	BUY	$189.27 - $231.83 $371,537 - $455,082	1,963 Added 25.39%	9,694 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$194.09 - $276.37 $1.5 Million - $2.14 Million	7,731 New	7,731 $1.54 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Waratah Capital Advisors Ltd., based on Form 13F filings with the SEC.

Stay updated on Waratah Capital Advisors Ltd. with notifications on news.